Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL1260645 | 1.00 | TSHR (0.31) | TSHRALDH1A1 | |
| Fluoride SCHEMBL1260646 | 0.96 | — | — | |
| SCHEMBL197824 | 0.96 | TSHR (0.33) | TSHRALDH1A1 | |
| Hydrogen Sulfide SCHEMBL28090943 | 0.96 | TSHR (0.33) | TSHRALDH1A1 | |
| Lithium Ion SCHEMBL2504315 | 0.92 | TSHR (0.31) | TSHRALDH1A1 | |
| Iodide SCHEMBL2796494 | 0.92 | TSHR (0.31) | TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL20896 | 0.92 | TSHR (0.31) | TSHRALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL4552701 | 0.92 | TSHR (0.31) | TSHRALDH1A1 | |
| SCHEMBL5327333 | 0.92 | TSHR (0.31) | TSHRALDH1A1 | |
| SCHEMBL5327324 | 0.92 | TSHR (0.31) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1742 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240083-A1 | ETCHING SOLUTION, METHOD OF MANUFACTURING SILICON DEVICE AND METHOD OF TREATING SUBSTRATE USING THE ETCHING SOLUTION | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | claimed |
| EP-4397670-A1 | STEROIDAL COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) | 2024-07-10 | — | — | EP | claimed |
| CN-114127227-B | Blue light emitting nanocrystals with cube shape and fluoride passivation | 昭荣化学工业株式会社 | 2024-05-14 | — | — | CN | claimed |
| CN-111433211-B | Synthesis of halichondrin | 哈佛大学的校长及成员们 | 2024-05-07 | — | — | CN | claimed |
| CN-117980318-A | Steroid compound, preparation method and application thereof | 广州润尔眼科生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20240116977-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-04-11 | — | — | US | claimed |
| CN-117625315-A | Fluorine-containing cleaning fluid composition and application thereof | 上海新阳半导体材料股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117625316-A | Preparation method of fluorine-containing cleaning fluid composition | 上海新阳半导体材料股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114269892-B | Composition and method for cleaning adhesive polymer | 株式会社力森诺科 | 2024-02-23 | — | — | CN | claimed |
| US-20240051986-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-15 | — | — | US | claimed |
| US-4803292-A | Process for producing statin and related compounds | SUNTORY LIMITED (JP) | 1989-02-07 | — | — | US | claimed |
| US-4771117-A | COCATALYST SYSTEM WITH A TETRACOORDIATE SILICONE ORGANIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-09-13 | — | — | US | claimed |
| EP-0224723-A1 | Process for the preparation of beta-hydroxyethyl-azole derivatives | BAYER AG (DE) | 1987-06-10 | — | — | EP | claimed |
| EP-0084199-B1 | METHOD OF PREPARING DELTA 5,7-STEROIDS | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1987-04-29 | — | — | EP | claimed |
| EP-0069696-B1 | DERIVATIVES OF 9-FLUOROPROSTAGLANDIN, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-01-15 | — | — | EP | claimed |
| US-4558148-A | REACTION OF SILANE METAL HALIDE WITH FLUORINATED CARBOXYLIC ACID ESTER | DAIKIN INDUSTRIES LTD. (JP) | 1985-12-10 | — | — | US | claimed |
| EP-0128725-A1 | Preparation of penem derivatives | PFIZER INC. (US) | 1984-12-19 | — | — | EP | claimed |
| US-4294959-A | Selectively protected 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols and their production | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | claimed |
| US-4055717-A | 9-(3-O-Acyl-β-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-β-D-arabinofuranosyl)-adenine compounds, and method for their production | PARKE, DAVIS & COMPANY (US) | 1977-10-25 | — | — | US | claimed |
| US-4048432-A | 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production | PARKE, DAVIS & COMPANY (US) | 1977-09-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240051986-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | POLRMT, NOP2, POLN | TSHR 2348/4885ALDH1A1 2533/4885 |
| US-20240116977-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMERS | NOP2, DIS3, POLRMT | TSHR 3238/4885ALDH1A1 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.